CRISPR Therapeutics
CRSP
#3064
Rank
C$5.72 B
Marketcap
$67.13
Share price
1.69%
Change (1 day)
-11.39%
Change (1 year)

Market capitalization of CRISPR Therapeutics (CRSP)

Market cap: C$5.72 Billion

As of November 2024 CRISPR Therapeutics has a market cap of C$5.72 Billion. This makes CRISPR Therapeutics the world's 3064th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of CRISPR Therapeutics from 2016 to 2024

End of year Market Cap

Year Marketcap Change
2024C$5.72 B-13.13%
2023C$6.59 B52.71%
2022C$4.31 B-41.57%
2021C$7.39 B-46.83%
2020C$13.90 B187.51%
2019C$4.83 B139.6%
2018C$2.01 B69.82%
2017C$1.18 B9.64%
2016C$1.08 B

End of Day market cap according to different sources

On Nov 14th, 2024 the market cap of CRISPR Therapeutics was reported to be:

C$5.63 Billion
by Nasdaq info icon info icon
C$5.63 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
C$0.83 B-85.50%๐Ÿ‡บ๐Ÿ‡ธ USA